(NASDAQ: TWST) Twist Bioscience's forecast annual revenue growth rate of 14.37% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.68%.
Twist Bioscience's revenue in 2026 is $409,479,000.On average, 12 Wall Street analysts forecast TWST's revenue for 2026 to be $28,352,129,264, with the lowest TWST revenue forecast at $27,156,520,035, and the highest TWST revenue forecast at $29,225,795,800. On average, 12 Wall Street analysts forecast TWST's revenue for 2027 to be $33,069,181,300, with the lowest TWST revenue forecast at $31,300,053,269, and the highest TWST revenue forecast at $34,739,297,941.
In 2028, TWST is forecast to generate $38,214,037,262 in revenue, with the lowest revenue forecast at $35,272,963,102 and the highest revenue forecast at $41,140,166,307.